oncology
-
MedCity Influencers, Consumer / Employer
Why Cancer Centers of Excellence May Not Be Right for Every Patient
The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.
-
I Used AI Tech To Find My Own Cancer Clinical Trial, and You Can Too
My phone chimed with a notification, signaling the availability of a new CT test result […]
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
A webinar sponsored by AVIA Health and SeamlessMD will discuss the latest trends in remote monitoring and how to extend these benefits beyond chronic conditions all while using fewer staff resources.
-
Why OneOncology Is Adopting Verily’s Clinical Trial Management System
OneOncology recently announced that it is deploying Verily’s clinical trial management platform across 11 of its community oncology clinics. Adopting Verily’s software will hopefully make clinical trial management much easier for OneOncology, which would allow the company to further democratize trials to improve health equity, the company’s chief medical officer said.
-
Cancer Moonshot: Would It Even Be Possible in Today’s Fee-For-Service World?
CMS’ Enhancing Oncology Model and Cancer Moonshot are the forcing functions to achieve value-based care in oncology. In the spirit of working together to improve lives, this is a MUST for physicians to consider–before they get left behind.
-
VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care
Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund’s founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.
-
MedCity Influencers, BioPharma
What A Nobel Prize-Winner’s Research Means for Cancer Treatment
Drs. Carolyn Bertozzi, Barry Sharpless, and Morten Meldal shared the 2022 Nobel Prize in Chemistry for greatly simplifying the synthesis of complicated molecules. Dr. Bertozzi’s protégé writes why her research is so important.
-
Avenda’s Platform for Personalized Prostate Cancer Mapping Earns FDA Clearance
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
-
MedCity Influencers, BioPharma, Health Tech
Digital Health in Oncology – Emerging Opportunities Across the Cancer Patient Journey
Cancer is a serious public health issue, accounting for nearly 10 million deaths and over […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
The cancer death rate is falling — focusing on equity and personalization will help it drop further
Fewer people are dying from cancer due to advances in research, screening and treatment, according to a new report. In order for the death rate to fall further, U.S. oncologists must prioritize personalized treatment and addressing social determinants of health, an expert argued.
-
Biopharma has a brand new target: Cancer-specific collagen
Researchers at the University of Texas MD Anderson Cancer Center published a new study revealing that cancer cells make their own unique form of collagen to help them grown and proliferate. This means drug developers may have a new, highly specific target for oncology therapeutics.
-
Cancer care poses challenges for employers; Transcarent shares vision for how it can help
As they seek to support their staff, self-insured employers are turning to innovative programs to balance evidence-based programs with the need to manage healthcare costs.
-
Judges: Joint winners at INVEST Pitch Perfect’s RPM track address large unmet need, have clear reimbursement path
San Francisco-based Blumio and Saint Paul, Minnesota-based NxGenPort tied for the top prize in the Remote Patient Monitoring and Smart Devices track of INVEST Pitch Perfect, the startup competition integral to MedCity News’ INVEST conference. Here is an in-depth look at each company.